Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | GPR3 | P46089 | 2/20 | 0.44 |
| ▸ | PARP1 | P09874 | 2/20 | 0.44 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.44 |
| ▸ | TNKS | O95271 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30174328 | 1.00 | KDM4E (0.47) | KDM4EALDH1A1HPGDHTTLMNA | |
| SCHEMBL3151147 | 0.88 | KDM4E (0.50) | KDM4EALDH1A1HPGDHTTLMNA | |
| SCHEMBL29757961 | 0.81 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDHTTLMNA | |
| SCHEMBL7726806 | 0.72 | CDC25A (0.51) | KDM4EALDH1A1HPGDHTTLMNA | |
| SCHEMBL28841465 | 0.72 | CCR6 (0.47) | KDM4EALDH1A1HPGDHTTLMNA | |
| Carbazole SCHEMBL28181847 | 0.69 | ALDH1A1 (0.61) | KDM4EALDH1A1HPGDHTTLMNA | |
| SCHEMBL21561768 | 0.69 | ALDH1A1 (0.56) | KDM4EALDH1A1HPGDHTTLMNA | |
| SCHEMBL16620312 | 0.68 | PARP1 (0.54) | KDM4EALDH1A1HPGDHTTLMNA | |
| SCHEMBL11793572 | 0.67 | CES1 (0.50) | KDM4EALDH1A1HPGDLMNACYP1A2 | |
| SCHEMBL30288157 | 0.67 | CES1 (0.50) | KDM4EALDH1A1HPGDLMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024067670-A1 | ANTIBODY AND CONJUGATE | 苏州智核生物医药科技有限公司 | 2024-04-04 | — | — | WO | claimed |
| CN-115322206-A | Condensed dioxy heterocorrole compound and preparation method thereof | 湖南科技大学 | 2022-11-11 | — | — | CN | claimed |
| WO-2024067670-A1 | ANTIBODY AND CONJUGATE | 苏州智核生物医药科技有限公司 | 2024-04-04 | — | — | WO | disclosed |
| CN-115850449-A | Antibodies and conjugates | 苏州智核生物医药科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115322206-A | Condensed dioxy heterocorrole compound and preparation method thereof | 湖南科技大学 | 2022-11-11 | — | — | CN | disclosed |
| EP-2509948-B1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2017-05-03 | — | — | EP | disclosed |
| US-9431616-B2 | Phosphaphenanthrene-carbazole-based organic light-emitting compound, and organic light-emitting device comprising same | INKTEC CO., LTD. (KR) | 2016-08-30 | — | — | US | disclosed |
| EP-2510400-B1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2015-04-29 | — | — | EP | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-20130161603-A1 | PHOSPHAPHENANTHRENE-CARBAZOLE-BASED ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | INKTEC CO., LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-12-06 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
| EP-2509948-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | Agfa-Gevaert (BE) | 2012-10-17 | — | — | EP | disclosed |
| EP-2510400-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | Agfa-Gevaert (BE) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011069943-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011069947-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | WEE1, CBX4, USP9X | KDM4E 1156/4885ALDH1A1 1029/4885HPGD 3146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.